VC firms take os­teo­poro­sis drug­mak­er Ra­dius Health pri­vate for al­most $900M

Af­ter at­tacks from ac­tivist in­vestors and dis­ap­point­ing re­turns on share prices, Ra­dius Health has now agreed to new own­er­ship, a di­rec­tion re­sult­ing in leav­ing the Nas­daq.

Ra­dius Health, a biotech out of Mass­a­chu­setts with one ap­proved prod­uct in its ar­se­nal, an­nounced Thurs­day morn­ing that it agreed to be ac­quired by two VC firms: Gur­net Point Cap­i­tal and Pa­tient Square Cap­i­tal. The deal, worth around $890 mil­lion, will in­clude debt as­sump­tion and the pay­out of $1 CVR per share for in­vestors. And on top of that, Or­biMed is pro­vid­ing debt fi­nanc­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER